Eton Pharmaceuticals, Inc. (ETON) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 6 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for ETON is $25.00, representing a -7.8% downside from the current price of $27.12. Price targets range from a low of $15.00 to a high of $35.00.
